Article Image

IPFS News Link • Vaccines and Vaccinations

What Happened To Pfizer Patient Zero Tiffany Dover?


On December 17, 2020, CHI Memorial Hospital nurse manager Tiffany Dover became one of the first American healthcare workers to receive Pfizer's novel mRNA-based COVID-19 vaccine.

With media crews on hand recording the public event, Dover was presented to the public for a post-injection interview with the hopes to promote future uptake in a product that was then considered a possible cure to the coronavirus.

"It's been a hard time," Dover said about the last year. "We've persevered through it, but I think that this vaccination offers us hope."

Suddenly, Dover's demeanor changed. "I'm sorry, I'm feeling a little dizzy," she added, holding her head, before fainting onto the ground.

After she was brought back to consciousness, a clearly shaken Dover later told the media that she regularly has an over-reactive vagal response (half a dozen recent fainting spells, she said), and added that was why she collapsed onto the ground after taking the shot.

Sure, It was a perplexing situation, as one could certainly question the wisdom of CHI Memorial sending someone with a known fainting condition for a post-injection live press conference. Nonetheless, at the time, it could be written off to simple bureaucratic foolishness.

With tens of billions of dollars in revenue on the line, and a "safe and effective" stamp of approval from the U.S. government, this was not the launch of a widespread marketing campaign that Pfizer and the Public Health establishment had hoped for.

But that was just the beginning of the Tiffany Dover mystery.